A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
Multiple Sclerosis, also known as M.S. is a chronic autoimmune disease that affects the brain and spinal cord. While the way ...
A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...
The trial aims to evaluate the antibody’s efficacy in treating non-active secondary progressive multiple sclerosis.
Nearly 50% of MS patients report pronounced fatigue, which has a significantly negative impact on their well-being, a Finnish ...
Sponsor:  OhioHealth The latest episode of The Wellness Conversation – an OhioHealth Podcast, delves into the complexities of ...
SAVANNAH, Ga. (WTOC) - March is Multiple Sclerosis awareness month. M.S. is a disease of the brain and spinal cord that ...
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...
Christina Applegate revealed she's been hospitalized more than 30 times in three years since being diagnosed with multiple ...